Lv11
50 积分 2023-08-09 加入
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
2小时前
待确认
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
2个月前
已完结
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
4个月前
已完结
Hepatic inflammatory responses in liver fibrosis
5个月前
已完结
Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy
5个月前
已完结
Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
5个月前
已完结
APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)
5个月前
已完结
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension
5个月前
已完结
Off-therapy cure of hepatitis delta after 3 years of bulevirtide monotherapy in a patient with compensated advanced cirrhosis
5个月前
已完结
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice
5个月前
已完结
皖公网安备34019202002308
